COMPLIMENTARY PASSES AVAILABLE TO QUALIFIED LIFE SCIENCES COMMUNICATORS

Must Be Director Level and Above to Qualify

See if you qualify. All registrations are subject to approval by Fierce Life Sciences.

Who Will You Be Joining?

Here's a small sample of attendees:

Sr. Manager Communications - North America, LEO Pharma

Director Digital Communications Oncology, Pfizer

Head, US Communications, Vaccines, Sanofi

Head, US Employee Engagement, Sanofi

Director, Social Media, Sanofi

Associate Director, U.S. Vaccines Communications, Sanofi

Associate Director, U.S. Transplant and Est. Prod, Sanofi

Director, Global Communications, Merck

Marketing manager, Lantern Pharma

Communications Manager, Currax Pharmaceuticals

Communications & Advocacy Head, Novartis Farmaceutica

Communications and Patient Advocacy Manager, Novartis

Senior Director, Customer Engagement, Harmony Biosciences

Senior Manager, Corporate Communications, Endo

Corporate Communications, Astellas Pharma US

Senior Vice President and Head of Investor Relations, Bristol Myers Squibb

Head of External Communications, AstraZeneca

Chief Corporate Communications Officer, Alnylam Pharmaceuticals

Senior Vice President, Corporate Affairs, Regeneron

Senior Vice President, Global Head, Corporate Affairs and Investor Relations, Galapagos

Senior Vice President Global Communications & Corporate Affairs, Genmab

Vice President, Corporate Communications, Bristol Myers Squibb

Chief Corporate Affair Officer, Viatris

Executive Vice President, Weber Shandwick

Head of Internal & Executive Communications, Otsuka Pharmaceuticals

Vice President, Corporate Affairs, Hansa Biopharma

AVP, Global and U.S. Human Health and Manufacturing Communications, Merck

Director of Corporate Reputation and Executive Communications, Boehringer Ingelheim Animal Health

Deputy Assistant Commissioner for Media Affairs, U.S. Food and Drug Administration (FDA)

Senior Vice President, Corporate Affairs & Investor Relations, Endo

Senior Director, Corporate Affairs, Endo

Vice President of Communications, Milestone Pharmaceuticals

Senior Director, Global R&D Communications, Daiichi Sankyo

Vice President, Global Corporate Communications, Amarin

Chief Corporate Affairs Officer, Hims & Hers

Vice President, Global Purpose & Patient Experience, Corporate Affairs, Bristol Myers Squibb

PR & Communciations Agenda at a Glance

MON

Sep 8

Registration

Marketing Workshop A

Rising Stars Workshop

Energizer Break

Marketing Workshop B

TUE

Sep 9

Registration & Networking Breakfast

General Sessions

Networking Break

General Sessions & Spotlight Stage Presentations

Networking Lunch

General Sessions & Spotlight Stage Presentations

Networking Break

General Sessions & Spotlight Stage Presentations

Networking Reception

WED

Sep 10

Registration & Networking Breakfast

Track Sessions & Spotlight Stage Presentations

Networking Break

Track Sessions & Spotlight Stage Presentations

Networking Lunch

Track Sessions & Spotlight Stage Presentations

Networking Reception

THU

Sep 11

Registration & Networking Breakfast

General Sessions or Medical Affairs Workshops

Networking Break

General Sessions or Medical Affairs Workshops

Networking Lunch

Conference Concludes

NEED MORE REASONS TO ATTEND?

Key topics covered in the PR & Communications Community

 

Corporate & Brand Reputation:

Focuses on building, maintaining, and protecting a company’s reputation in a competitive and often skeptical landscape. Sessions explore brand positioning, corporate responsibility, DEI communications, and strategies to safeguard trust during crises and political shifts

 

0

 

Strategic Product Communication:

Explores how to effectively communicate product value across stakeholder groups—including patients, media, and HCPs—while reinforcing broader corporate messaging. Sessions will cover tactics to build trust, drive awareness, and position products competitively in an evolving marketplace.

 

0

 

Evolving Media & Technology Trends:

Examines how technology like AI and social media are reshaping communication strategies and risk management. This track will address misinformation, deepfakes, and how to integrate emerging tools to stay ahead of trends without losing the human element

 

0

Stakeholder Relationship Management:

Highlights strategies for building transparent, meaningful relationships with investors, employees, patients, and community voices. This track dives into investor relations, patient engagement, and the role of communicators in guiding C-suite decisions that shape corporate reputation and value.

 

0

 

Access every session across Marketing, PR, Medical Affairs and Commercialization!

4
Engaged Communities
17
Targeted Tracks
200+
Can't Miss Sessions
400+
Expert Speakers
2200+
Pharma Leaders in One Place

Let's work together!

Find out why Fierce Pharma Week is the ultimate networking opportunity to reach key decision makers across every corner of the biopharma ecosystem.